IL1B and rosacea: AzA’s anti-inflammatory activity is mediated through the downregulation of pro-inflammatory cytokines, including interleukin-1 beta (IL-1β) and tumor necrosis factor-alpha (TNF-α), which are key drivers of inflammation in acne and rosacea pathophysiology.